![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 18, 12537-12543, April 30, 1999
,
,
, and
From the The peptidoglycan of Gram-positive bacteria is
known to trigger cytokine release from peripheral blood mononuclear
cells (PBMCs). However, it requires 100-1000 times more Gram-positive
peptidoglycan than Gram-negative lipopolysaccharide to release the same
amounts of cytokines from target cells. Thus, either peptidoglycan is poorly active or only part of it is required for PBMC activation. To
test this hypothesis, purified Streptococcus pneumoniae
walls were digested with their major autolysin
N-acetylmuramoyl-L-alanine amidase, and/or
muramidase. Solubilized walls were separated by reverse phase high
pressure chromatography. Individual fractions were tested for their
PBMC-stimulating activity, and their composition was determined.
Soluble components had a Mr between 600 and
1500. These primarily comprised stem peptides cross-linked to various extents. Simple stem peptides (Mr <750) were
10-fold less active than undigested peptidoglycan. In contrast,
tripeptides (Mr >1000) were
Division of Infectious Diseases, Department
of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011
Lausanne, Switzerland and § Pharmaceutical Research-Gene
Technologies, F. Hoffman-La Roche Ltd.,
CH-4070 Basel, Switzerland
100-fold more
potent than the native material. One dipeptide (inactive) and two
tripeptides (active) were confirmed by post-source decay analysis.
Complex branched peptides represented
2% of the total material, but
their activity (w/w) was almost equal to that of LPS. This is the first
observation suggesting that peptidoglycan stem peptides carry high
tumor necrosis factor-stimulating activity. These types of structures
are conserved among Gram-positive bacteria and will provide new
material to help elucidate the mechanism of peptidoglycan-induced inflammation.
This article has been cited by other articles:
![]() |
I. Valera, A. G. Vigo, S. Alonso, L. Barbolla, M. S. Crespo, and N. Fernandez Peptidoglycan and mannose-based molecular patterns trigger the arachidonic acid cascade in human polymorphonuclear leukocytes J. Leukoc. Biol., April 1, 2007; 81(4): 925 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Moore, A. M. Gilbey, C. G. Dowson, A. C. Pridmore, S. K. Dower, and R. C. Read Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to {beta}-lactam antibiotics J. Antimicrob. Chemother., January 1, 2007; 59(1): 35 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fillon, K. Soulis, S. Rajasekaran, H. Benedict-Hamilton, J. N. Radin, C. J. Orihuela, K. C. El Kasmi, G. Murti, D. Kaushal, M. W. Gaber, et al. Platelet-Activating Factor Receptor and Innate Immunity: Uptake of Gram-Positive Bacterial Cell Wall into Host Cells and Cell-Specific Pathophysiology J. Immunol., November 1, 2006; 177(9): 6182 - 6191. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Santos-Sierra, D. T. Golenbock, and P. Henneke Toll-like receptor-dependent discrimination of streptococci Innate Immunity, October 1, 2006; 12(5): 307 - 312. [Abstract] [PDF] |
||||
![]() |
C. J. Orihuela, S. Fillon, S. H. Smith-Sielicki, K. C. El Kasmi, G. Gao, K. Soulis, A. Patil, P. J. Murray, and E. I. Tuomanen Cell Wall-Mediated Neuronal Damage in Early Sepsis Infect. Immun., July 1, 2006; 74(7): 3783 - 3789. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Nash, T. N. S. Ballard, T. E. Weaver, and H. T. Akinbi The Peptidoglycan-Degrading Property of Lysozyme Is Not Required for Bactericidal Activity In Vivo J. Immunol., July 1, 2006; 177(1): 519 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Visser, H. Jan de Heer, L. A. Boven, D. van Riel, M. van Meurs, M.-J. Melief, U. Zahringer, J. van Strijp, B. N. Lambrecht, E. E. Nieuwenhuis, et al. Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease J. Immunol., January 15, 2005; 174(2): 808 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Myhre, J. F. Stuestol, M. K. Dahle, G. Overland, C. Thiemermann, S. J. Foster, P. Lilleaasen, A. O. Aasen, and J. E. Wang Organ Injury and Cytokine Release Caused by Peptidoglycan Are Dependent on the Structural Integrity of the Glycan Chain Infect. Immun., March 1, 2004; 72(3): 1311 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-M. Wang, X. Li, R. R. Cocklin, M. Wang, M. Wang, K. Fukase, S. Inamura, S. Kusumoto, D. Gupta, and R. Dziarski Human Peptidoglycan Recognition Protein-L Is an N-Acetylmuramoyl-L-alanine Amidase J. Biol. Chem., December 5, 2003; 278(49): 49044 - 49052. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Simelyte, M Rimpilainen, X Zhang, and P Toivanen Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis Ann Rheum Dis, October 1, 2003; 62(10): 976 - 982. [Abstract] [Full Text] |
||||
![]() |
E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Majcherczyk, E. Rubli, D. Heumann, M. P. Glauser, and P. Moreillon Teichoic Acids Are Not Required for Streptococcus pneumoniae and Staphylococcus aureus Cell Walls To Trigger the Release of Tumor Necrosis Factor by Peripheral Blood Monocytes Infect. Immun., July 1, 2003; 71(7): 3707 - 3713. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ganz, V. Gabayan, H.-I Liao, L. Liu, A. Oren, T. Graf, and A. M. Cole Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan Blood, March 15, 2003; 101(6): 2388 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, M. Rimpilainen, and P. Toivanen Enzyme Degradation and Proinflammatory Activity in Arthritogenic and Nonarthritogenic Eubacterium aerofaciens Cell Walls Infect. Immun., December 1, 2001; 69(12): 7277 - 7284. [Abstract] [Full Text] [PDF] |
||||
![]() |
X Zhang, M Rimpilainen, and P Toivanen Characterisation of Eubacterium cell wall: peptidoglycan structure determines arthritogenicity Ann Rheum Dis, March 1, 2001; 60(3): 269 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Kozar, M. T. Krahmer, A. Fox, and B. M. Gray Failure To Detect Muramic Acid in Normal Rat Tissues but Detection in Cerebrospinal Fluids from Patients with Pneumococcal Meningitis Infect. Immun., August 1, 2000; 68(8): 4688 - 4698. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Simelyte, M. Rimpilainen, L. Lehtonen, X. Zhang, and P. Toivanen Bacterial Cell Wall-Induced Arthritis: Chemical Composition and Tissue Distribution of Four Lactobacillus Strains Infect. Immun., June 1, 2000; 68(6): 3535 - 3540. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |